15-100099999-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_139057.4(ADAMTS17):​c.2017-3523A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.633 in 152,098 control chromosomes in the GnomAD database, including 30,742 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.63 ( 30742 hom., cov: 32)

Consequence

ADAMTS17
NM_139057.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.617

Publications

2 publications found
Variant links:
Genes affected
ADAMTS17 (HGNC:17109): (ADAM metallopeptidase with thrombospondin type 1 motif 17) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. ADAMTS family members share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature protein, which may promote breast cancer cell growth and survival. Mutations in this gene are associated with a Weill-Marchesani-like syndrome, which is characterized by lenticular myopia, ectopia lentis, glaucoma, spherophakia, and short stature. [provided by RefSeq, May 2016]
ADAMTS17 Gene-Disease associations (from GenCC):
  • Weill-Marchesani 4 syndrome, recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Orphanet, Ambry Genetics, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.726 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139057.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAMTS17
NM_139057.4
MANE Select
c.2017-3523A>G
intron
N/ANP_620688.2Q8TE56-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAMTS17
ENST00000268070.9
TSL:1 MANE Select
c.2017-3523A>G
intron
N/AENSP00000268070.4Q8TE56-1
ADAMTS17
ENST00000961098.1
c.2017-3523A>G
intron
N/AENSP00000631157.1
ADAMTS17
ENST00000568565.2
TSL:5
c.2017-3523A>G
intron
N/AENSP00000456161.2H3BRA9

Frequencies

GnomAD3 genomes
AF:
0.633
AC:
96199
AN:
151980
Hom.:
30707
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.691
Gnomad AMI
AF:
0.649
Gnomad AMR
AF:
0.662
Gnomad ASJ
AF:
0.619
Gnomad EAS
AF:
0.570
Gnomad SAS
AF:
0.747
Gnomad FIN
AF:
0.578
Gnomad MID
AF:
0.617
Gnomad NFE
AF:
0.597
Gnomad OTH
AF:
0.614
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.633
AC:
96294
AN:
152098
Hom.:
30742
Cov.:
32
AF XY:
0.635
AC XY:
47255
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.692
AC:
28686
AN:
41482
American (AMR)
AF:
0.661
AC:
10113
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.619
AC:
2148
AN:
3470
East Asian (EAS)
AF:
0.571
AC:
2944
AN:
5158
South Asian (SAS)
AF:
0.746
AC:
3596
AN:
4820
European-Finnish (FIN)
AF:
0.578
AC:
6123
AN:
10590
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.597
AC:
40610
AN:
67972
Other (OTH)
AF:
0.616
AC:
1300
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1784
3568
5352
7136
8920
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
786
1572
2358
3144
3930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.543
Hom.:
2716
Bravo
AF:
0.641
Asia WGS
AF:
0.663
AC:
2309
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.4
DANN
Benign
0.54
PhyloP100
-0.62
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8027190; hg19: chr15-100640204; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.